A detailed history of Dimensional Fund Advisors LP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 394,473 shares of RVMD stock, worth $17.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
394,473
Previous 390,583 1.0%
Holding current value
$17.9 Million
Previous $15.2 Million 17.91%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$36.92 - $47.94 $143,618 - $186,486
3,890 Added 1.0%
394,473 $17.9 Million
Q2 2024

Aug 09, 2024

SELL
$30.14 - $40.68 $28.4 Million - $38.3 Million
-940,676 Reduced 70.66%
390,583 $15.2 Million
Q1 2024

May 10, 2024

SELL
$26.56 - $33.55 $12.3 Million - $15.6 Million
-464,162 Reduced 25.85%
1,331,259 $42.9 Million
Q4 2023

Feb 07, 2024

BUY
$18.35 - $34.12 $2.45 Million - $4.56 Million
133,558 Added 8.04%
1,795,421 $51.5 Million
Q3 2023

Nov 09, 2023

SELL
$25.17 - $35.05 $174,000 - $242,300
-6,913 Reduced 0.41%
1,661,863 $46 Million
Q2 2023

Aug 09, 2023

BUY
$20.28 - $27.0 $1.19 Million - $1.59 Million
58,789 Added 3.65%
1,668,776 $44.6 Million
Q1 2023

May 12, 2023

BUY
$20.76 - $30.09 $9.55 Million - $13.8 Million
460,094 Added 40.01%
1,609,987 $34.9 Million
Q4 2022

Feb 09, 2023

BUY
$17.68 - $25.53 $3.77 Million - $5.45 Million
213,377 Added 22.78%
1,149,893 $27.4 Million
Q3 2022

Nov 10, 2022

BUY
$17.46 - $26.0 $5.34 Million - $7.95 Million
305,819 Added 48.49%
936,516 $18.5 Million
Q2 2022

Aug 12, 2022

BUY
$14.54 - $27.17 $2.21 Million - $4.13 Million
151,921 Added 31.73%
630,697 $12.3 Million
Q1 2022

May 13, 2022

BUY
$17.31 - $26.4 $5.17 Million - $7.88 Million
298,436 Added 165.49%
478,776 $12.2 Million
Q4 2021

Feb 09, 2022

BUY
$24.35 - $33.7 $3.72 Million - $5.15 Million
152,940 Added 558.18%
180,340 $4.54 Million
Q3 2021

Nov 12, 2021

BUY
$23.95 - $33.41 $656,230 - $915,433
27,400 New
27,400 $754,000

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.97B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.